Skip to Content

Davabazaar in India Vision and Objective

Sun, 10/11/2009 - 14:34 — Bhekare

Davabazaar in India website is a Pharma Trade Portal which caters to end patients and their relatives, chemist and medical stores, pharmacist and other pharma workers, doctors and nursing homes, hospitals and medical institutions, pharmaceutical manufactures and allied service providers, trade and manufactures associations.

For patients and relatives we have Ask-the-Doctor medical forums, health blogs, chats and patient health communities.

Drug Index Software

Mon, 10/05/2009 - 15:58 — Correspondent

Very soon the drug index software will be available for download. This software and all further upgrades are available free of cost to chemist and medical doctors. Please register and get yourself verified. Pharmaceutical companies who wish to add their information should also register and get verified.

Correspondent's picture

Pharma Overview

Wed, 08/12/2009 - 00:24 — Correspondent

Pharmaceutical OverviewLast Updated: April 2009

Sector structure/Market size


The Indian pharmaceutical industry is driving product development and breaking new grounds in medicine research worldwide.


The Indian domestic pharmaceutical market is estimated to be US$ 10.76 billion in 2008 and is expected to grow at a high compound annual growth rate (CAGR) of 9.9 per cent till 2010 and thereafter at a CAGR of 9.5 per cent till 2015.

Correspondent's picture

Roche and Biogen Idec decide to suspend Ocrelizumab treatment

Thu, 03/11/2010 - 04:31 — Correspondent

Roche and Biogen Idec announced their decision to suspend Ocrelizumab treatment of patients in the Rheumatoid Arthritis (RA) programme. The decision follows the recommendation of the independent Ocrelizumab RA & Lupus Data and Safety Monitoring Board (DSMB) based on their assessment of the studies in RA (SCRIPT, FEATURE, FILM and STAGE) and lupus (BELONG and BEGIN).

Correspondent's picture

Full Issue

Thu, 03/11/2010 - 02:30 — Correspondent

View the entire issue.

Correspondent's picture

Watson, Takeda Settle Patent Lawsuit Over Generic Actos

Thu, 03/11/2010 - 02:30 — Correspondent

Takeda Chemical Industries and Takeda Pharmaceuticals North America have settled a patent lawsuit with Watson Pharmaceuticals over the Actos diabetes
drug.

Correspondent's picture

Actavis Responds to DDMAC Letter on Kadian Claims, Risks

Thu, 03/11/2010 - 02:30 — Correspondent

Actavis Elizabeth has met the deadline for responding to an FDA warning letter that cited its marketing materials for its Kadian pain drug for omitting
risks and overstating the drug’s efficacy.

Correspondent's picture

FDA Warns Paddock for Production of Unapproved Narcotic

Thu, 03/11/2010 - 02:30 — Correspondent

Paddock Laboratories has until July 24 to submit a supplemental NDA for its oral morphine sulfate solution to treat pain.

Correspondent's picture

GSK Asks Court to Block Teva Launch of Generic Combivir

Thu, 03/11/2010 - 02:30 — Correspondent

GlaxoSmithKline (GSK) is seeking an injunction in federal court to bar Teva Pharmaceuticals USA from selling a generic version of GSK’s HIV drug
Combivir.

Correspondent's picture

Sharfstein: FDA to Release Track-and-Trace Guidance

Thu, 03/11/2010 - 02:30 — Correspondent

The FDA plans to release a new guidance establishing a standard for unique identification for prescription drug packages.

Syndicate content


Theme by Dr. Radut.